---
title: "Rundu Pharma: Passed the on-site inspection by the European Medicines Agency"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260394183.md"
description: "Rundu Pharma announced that from May 14, 2025, to May 16, 2025, the company underwent an on-site GMP inspection of the active pharmaceutical ingredient CEP by the European Directorate for the Quality of Medicines & HealthCare (EDQM). Recently, the company received the \"Inspection Certificate\" issued by EDQM, and the inspection was successfully passed"
datetime: "2025-10-09T08:13:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260394183.md)
  - [en](https://longbridge.com/en/news/260394183.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260394183.md)
generator: "portal-rs"
---

# Rundu Pharma: Passed the on-site inspection by the European Medicines Agency

Rundu Pharma announced that from May 14, 2025, to May 16, 2025, the company underwent an on-site GMP inspection of the active pharmaceutical ingredient CEP by the European Directorate for the Quality of Medicines & HealthCare (EDQM). Recently, the company received the "Inspection Certificate" issued by EDQM, and the inspection was successfully passed

### Related Stocks

- [002923.CN](https://longbridge.com/en/quote/002923.CN.md)

## Related News & Research

- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [Scott Bessent Brings His Hedge Fund Playbook To Treasury. The Bond Market Is Fighting Back](https://longbridge.com/en/news/296520391.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [FOCUS-Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak](https://longbridge.com/en/news/296469939.md)
- [Mexican governor, indicted by US on cartel charges, requests leave again amid backlash](https://longbridge.com/en/news/296689811.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**